September 18, 2017
review the DRAFT Administration of Influenza Vaccines to Egg-Allergic Recipients: A Practice Parameter Update - 2017
At the request of the Joint Task Force on Practice Parameters, you are invited to review the DRAFT Administration of Influenza Vaccines to Egg-Allergic Recipients: A Practice Parameter Update - 2017. The Joint Task Force will be taking comments until October 2, 2017. To provide your suggested revisions and/or comments, using a Word document, please list the page and line number before your revision/recommendation and forward to Natalie Aumann at NAumann@aaaai.org
. Please take advantage of this opportunity to assist your colleagues in shaping the specialty. CLICK HERE FOR DRAFT.
The workgroup developing this document are: Matthew Greenhawt, MD, MBA, MSc, Paul J. Turner, BM, BCh, FRACP, PhD and John M. Kelso, MD.
Thank you for your participation in this important process.
September 7, 2017
FDA Acknowledges Qualified Health Claim Linking Early Peanut Introduction and Reduced Risk of Developing Peanut Allergy
The U.S. Food and Drug Administration (FDA) has announced a major change in food labeling regarding peanut allergy in infants. The claim, which manufacturers can use immediately, reads:
“For most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age. FDA has determined, however, that the evidence supporting this claim is limited to one study.
If your infant has severe eczema and/or egg allergy, check with your infant’s healthcare provider before feeding foods containing ground peanuts."
Read the FDA’s announcement here.